Home LiteratureArticle Details
PMID: 9002445 Published · ppublish English Journal Article

Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes.

Immunogenetics ·Vol. 45 ·No. 4 ·1997-00-00 ·Pages 249-58

Kondo A, Sidney J, Southwood S, del Guercio MF, Appella E, Sakamoto H, Grey HM, Celis E, Chesnut RW, Kubo RT, Sette A

Abstract

Previous studies have defined two different peptide binding motifs specific for HLA-A*0101. These motifs are characterized by the presence of tyrosine (Y) at the C-termini of 9-mer and 10-mer peptides, and either a small polar or hydrophobic (S, T, M) residue in position 2, or a negatively charged (D or E) residue in position 3. In this study, the structural requirements for peptide binding to A*0101 have been further analyzed by examining the binding capacity of large sets of peptides corresponding to naturally occurring sequences which bore one or the other of these two A*0101-specific motifs. By correlating the presence of specific residue types at each position along the peptide sequence with increased (or decreased) binding affinity, the prominent influence of secondary anchor residues was revealed. In most cases, the two anchors in positions 2 and 3 appear to act synergistically. With the exception of the DE3 submotif in 9-mer peptides, a positive role for aromatic residues in position 1 and the center of the peptide (positions 4 or 5 of 9- or 10-mer peptides, respectively), and proline at C-3, were also consistently detected. However, secondary anchor residues also appear to differ significantly between the two different submotifs, demonstrating that A*0101 can utilize alternative modes in binding its peptide ligands. According to these analyses, specific refined submotifs were also established, and their merit verified by independent sets of potential A*0101 binding peptides. Besides providing useful insight into the nature of the interaction of the A*0101 allele with its peptide ligands, such refined motifs should also facilitate accurate prediction of potential A*0101-restricted peptide epitopes.

MeSH Terms
Binding Sites Cell Line, Transformed HLA-A Antigens/immunology Humans Ligands Peptides/chemistry,immunology Structure-Activity Relationship
Chemicals
HLA-A Antigens Ligands Peptides
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Kondo A
Takara Shuzo Co., Ltd., Biotechnology Research Laboratories, SETA 3-4-1, OTSU, SHIGA, 520-21, Japan.
Sidney J
Southwood S
del Guercio M F
Appella E
Sakamoto H
Grey H M
Celis E
Chesnut R W
Kubo R T
Sette A
Article Info
Journal
Immunogenetics
Abbr.
Immunogenetics
ISSN
0093-7711
Published
1997-00-00
Pages
249-58
Language
English
Region
United States
NLM ID
0420404
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com